Why is the Ramsay (ASX:RHC) share price so volatile today?

COVID is hitting Ramsay's operations…

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Ramsay Health Care Limited (ASX: RHC) share price has pulled back from its intraday highs in afternoon trade.

At the time of writing, the private hospital operator's shares are up 0.5% to $68.00.

This compares to a 2% gain for the Ramsay share price in earlier trade.

A male doctor wearing a white lab coat shrugs his shoulders and holds his hands up in the air looking confused

Image source: Getty Images

What did Ramsay announce?

This afternoon Ramsay released an update in relation to the impact that COVID-19 restrictions are having on its operations.

It notes that the NSW Ministry of Health will introduce restrictions on non-urgent overnight Category 2 and Category 3 elective surgeries at all private hospitals in the state effective 10 January.

Category 2 admission relates to a condition which is not likely to deteriorate quickly or become an emergency within 90 days. Whereas a Category 3 admission is unlikely to deteriorate quickly and has little potential to become an emergency within 365 days.

In addition to this, Ramsay highlights that similar changes were made by the Victorian Department of Health and Human Services (DHHS) to surgical restrictions on 6 January. Elective surgery is now restricted to urgent elective surgery procedures.

Further, neither the DHHS nor the NSW Ministry of Health have provided a date for when these restrictions will end and Ramsay will be able to return to business as usual.

What will the impact be?

Ramsay has warned that these and previous surgical restrictions will have a material impact on its earnings in FY 2022. For example, it notes that in the first quarter, COVID related disruptions and costs impacted its Australian earnings by $55 million.

And while January is the seasonally quietest month of the year in the Australian business, it remains unclear when the current wave of Omicron cases will subside and Ramsay will be able to operate as normal again. This could see the restrictions creep into busier months.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has recommended Ramsay Health Care Limited. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Healthcare Shares

A man in a shirt and tie looks to the horizon holding his hand above his eyes as if to shield the sun so he can see better.
Healthcare Shares

Why is everyone talking about 4DX shares this week?

It's all eyes on the healthcare stock this week.

Read more »

A bearded man holds both arms up diagonally and points with his index fingers to the sky with a thrilled look on his face.
Healthcare Shares

$10,000 invested in this ASX healthcare share a year ago is now worth $36,500

This stock has experienced a dramatic price increase.

Read more »

A male doctor and a woman in scrubs in the foreground smile.
Healthcare Shares

The ASX healthcare stocks with the biggest upside according to brokers

These two healthcare stocks could be value buys.

Read more »

Cropped shot of a young female scientist working on her computer in the laboratory.
Healthcare Shares

Here's one reason why experts think the CSL share price can rise 65%!

There’s more than one reason why experts are excited by the potential of CSL.

Read more »

Six smiling health workers pose for a selfie.
Healthcare Shares

Forget DroneShield and EOS, this ASX healthcare stock is up 15x in a year!

There is no doubt that 4DMedical is one of the hottest stocks on the ASX right now.

Read more »

Scientists in white coats look disappointed.
Healthcare Shares

$5,000 invested in CSL shares 12 months ago is now worth…

Are the biotech company's shares worth holding onto?

Read more »

Happy healthcare workers in a lab.
Healthcare Shares

Clarity Pharmaceuticals shares are up 12% today. Here's what's driving the move

Today's announcement moves Clarity a step closer towards commercialisation.

Read more »

A medical specialist holds a red heart connected via technology and artificial intelligence.
Healthcare Shares

Which ASX biotech's shares are rocketing higher on big US news?

This company has more than doubled in value over the past three months.

Read more »